ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.42
1.29%
US Tech 100
19,634.80
0.80%
S&P 500
5,537.02
0.51%
US Dollar vs CAD
1.36391
-0.28%
Bitcoin
60,127.50
-3.06%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
07/03/20243:57AMAlliance NewsAlliance NewsAptamer shares jump as inks agreement with AstraZenecaLSE:AZNAstrazeneca Plc
07/03/20243:57AMAlliance NewsAlliance NewsAptamer shares jump as inks agreement with AstraZenecaLSE:AZNAstrazeneca Plc
07/01/20249:00AMRNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
07/01/20243:13AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca cancer and Covid drugs recommended for approvalLSE:AZNAstrazeneca Plc
07/01/20243:13AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca cancer and Covid drugs recommended for approvalLSE:AZNAstrazeneca Plc
07/01/20241:00AMRNS Regulatory NewsAstraZeneca PLC Lynparza & Imfinzi positive CHMP in endometrialLSE:AZNAstrazeneca Plc
06/26/20242:40AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
06/26/20242:40AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
06/25/20243:05AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
06/25/20243:05AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
06/25/20241:05AMRNS Regulatory NewsAstraZeneca PLC Update on Imfinzi ADJUVANT BR.31 trialLSE:AZNAstrazeneca Plc
06/25/20241:00AMRNS Regulatory NewsAstraZeneca PLC Imfinzi improved EFS and OS in bladder cancerLSE:AZNAstrazeneca Plc
06/20/20244:56AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
06/20/20244:56AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
06/18/20243:33AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
06/18/20243:33AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
06/18/20241:00AMRNS Regulatory NewsAstraZeneca PLC Update on CAPItello-290 Phase III trialLSE:AZNAstrazeneca Plc
06/17/20243:09AMAlliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
06/17/20243:09AMAlliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
06/17/20241:23AMAlliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
06/17/20241:23AMAlliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
06/17/20241:00AMRNS Regulatory NewsAstraZeneca PLC Imfinzi approved in the US for endometrial cancerLSE:AZNAstrazeneca Plc
06/12/20242:56PMAlliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
06/12/20242:56PMAlliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
06/12/20249:00AMRNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
06/10/20242:30AMAlliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
06/10/20242:30AMAlliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
06/05/20243:27AMAlliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
06/05/20243:27AMAlliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
06/05/20241:00AMRNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

NASDAQ
TSLA
Tesla
AMEX
OPTT
Ocean Power Technologies
USOTC
KEGS
1812 Brewing (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
NSAV
Net Savings Link (PK)
USOTC
CNNA
Cann American (CE)
USOTC
MGON
Megola (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
SPZI
Spooz (PK)
USOTC
NLST
Netlist (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
ENZC
Enzolytics (PK)
NASDAQ
COOP
Mr Cooper
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved